MENU
TCRX
AS OF
Nov 13, 04:59 PM (EDT)
Price
$1.13
Change
-$0.06 (-5.04%)
Capitalization
67.53M
118 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
TCRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TScan Therapeutics (TCRX) Earnings Date & Reports

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer... Show more

A.I. Advisor
published Earnings

TCRX is expected to report earnings to rise 13.14% to -31 cents per share on March 11

TScan Therapeutics TCRX Stock Earnings Reports
Q4'25
Est.
$-0.32
Q3'25
Beat
by $0.06
Q2'25
Beat
by $0.05
Q1'25
Beat
by $0.54
Q4'24
Missed
by $0.01
The last earnings report on November 12 showed earnings per share of -28 cents, beating the estimate of -34 cents. With 375.30K shares outstanding, the current market capitalization sits at 67.53M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
TCRX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TCRX showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for TCRX
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
830 Winter Street
Phone
+1 857 399-9500
Employees
154
Web
https://www.tscan.com